[1] He J, Lu H, Zou Q, et al. Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish. Gastroenterology,2014,146:789-800 e8.
[2] Eisenstein M. Organoids: the body builders. Nature Methods,2018,15:19-22.
[3] Marsee A, Roos FJM, Verstegen MMA, et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell, 2021,28:816-832.
[4] Huch M, Gehart H, van Boxtel R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell,2015,160:299-312.
[5] Huch M, Dorrell C, Boj SF, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature,2013,494:247-250.
[6] Peng WC, Logan CY, Fish M, et al. Inflammatory Cytokine TNFalpha Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture. Cell,2018,175:1607-1619 e15.
[7] Hu H, Gehart H, Artegiani B, et al. Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids. Cell,2018,175:1591-1606 e19.
[8] Tanimizu N, Ichinohe N, Sasaki Y, et al. Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo. Nat Commun,2021,12:3390.
[9] Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature,2013,499:481-484.
[10] Koike H, Iwasawa K, Ouchi R, et al. Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary. Nature,2019,574:112-116.
[11] Ogawa M, Jiang JX, Xia S, et al. Generation of functional ciliated cholangiocytes from human pluripotent stem cells. Nat Commun,2021,12:6504.
[12] Sampaziotis F, Muraro D, Tysoe OC, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science,2021,371:839-846.
[13] Lu WY, Bird TG, Boulter L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol,2015,17:971-983.
[14] Sampaziotis F, de Brito MC, Madrigal P, et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol, 2015,33:845-852.
[15] Koui Y, Kido T, Ito T, et al. An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells. Stem Cell Reports,2017,9:490-498.
[16] Coll M, Perea L, Boon R, et al. Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. Cell Stem Cell, 2018,23:101-113 e7.
[17] Ouchi R, Togo S, Kimura M, et al. Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids. Cell Metab,2019,30:374-384.e6.
[18] Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater,2021,6:402-420.
[19] Stevens KR, Scull MA, Ramanan V, et al. In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease. Sci Transl Med,2017,9:eaah5505. |
